Technology
Latest news, analysis, and insights from ASX technology companies
Sparc Technologies Building a Scalable Path to Commercial Graphene Technology
SPN hits first commercial sale of ecosparc, the graphene additive set to embed in global coatings, signaling a scalable, high-margin move from lab to market.
Latest Stories
DorsaVi Advances Edge AI and Robotics Strategy with 22nm RRAM Tests
DorsaVi kicks off 180-nm RRAM testing as it targets a 22-nm edge AI/robotics platform, boosting neuromorphic ambitions amid FY25 revenue decline.
InteliCare Signs $8.8m Deal to Deploy Aged Care Technology Platform into Victorian Residential Facilities
InteliCare inks $8.8m 5-year deal to roll out its predictive analytics IoT platform across mecwacare's Victorian facilities, largest contract yet.
RocketDNA Launches Testing Phase of Skylink Software Platform with Global Mining Customer
RocketDNA (ASX: RKT) launches Skylink testing phase with Tier-1 mining client, delivering real-time drone data and on-demand missions at scale.
BluGlass Lands A$1.25M Defence Program With US Tier-1 Prime Customer
BluGlass lands A$1.25m GaN laser defence program with US Tier-1 prime; initial A$560k order, 14–20 month milestones, boosts US footprint.
Spenda Raises $1.4M in Private Placement Amidst Significant Dilution Concerns
Spenda launches $1.4M private placement, issuing 700m shares; directors subscribing-dilution risk ahead.
Archer Materials is Building a Scalable Path to Commercial Quantum Technology
Archer Materials (ASX: AXE) charts a scalable, semiconductor-ready path to commercial quantum tech with the 12CQ project, targeting a 2026 qubit.
Noviqtech Subsidiary Coralia Advances Sustainable Infrastructure Mission with DCA Membership
NVQ's Coralia joins DCA as an affiliate, accelerating biochar-based cement decarbonisation for Australian data centres and hyperscalers.
Control Bionics Bolsters European Expansion with German Reimbursement for NeuroNode
Control Bionics (ASX: CBL) secures German reimbursement for NeuroNode, fueling Europe wholesale push and distributor ramp-up amid funding risks.
FBR Boosts Hadrian Homes Scaling Strategy with AMOVEO WaaS Offtake Agreement
FBR inks binding AMOVEO offtake for Hadrian Homes: 5400m2 wall over 24 months, AUD 400k–450k; aims to deliver ~200 homes in 12 months.
ArchTIS Lands US/EU Military Alliance Contract for NC Protect, Secures A$8M Facility
ArchTIS wins US/EU military alliance contract for NC Protect; up to A$1.22m potential, plus A$8m banking facility to fund US expansion.
Control Bionics Signs US JV for iOS Speech Devices with NextLevel Assistive Technology
Control Bionics inks exclusive US JV with NextLevel for iOS speech devices, FDA Manufacturer of Record; aims 1,000–1,500 units/year in a USD 100–150m market.